abstract |
The present invention relates to compounds of formula (I) which are inhibitors of activated thrombin-activateable fibrinolysis inhibitors. Formula I The compounds of formula (I) are suitable for the manufacture of a medicament for the prevention, secondary prevention and treatment of one or more disorders associated with thrombosis, embolism, hypercoagulation or fibrotic change. |